ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19

Mostrar otras versiones (1)

The pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has resulted in several thousand deaths worldwide in just a few months. Patients who died from Coronavirus disease 2019 (COVID-19) often had comorbidities, such as hypertension, diabetes, and chronic obstructive...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Bruna G.G., Oliveira, Antonio E.R., Singh, Youvika, Jimenez, Leandro, Gonçalves, Andre N A., Ogava, Rodrigo L.T., Creighton, Rachel, Peron, Jean Pierre Schatzmann, Nakaya, Helder I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276054/
https://www.ncbi.nlm.nih.gov/pubmed/32511627
http://dx.doi.org/10.1101/2020.03.21.20040261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276054/
https://www.ncbi.nlm.nih.gov/pubmed/32511627
http://dx.doi.org/10.1101/2020.03.21.20040261

Ejemplares similares